Echo Therapeutics (ECTE)
Add to Watchlists Create an AlertEcho Therapeutics Enterprise Value:
25.32M for May 23, 2013Echo Therapeutics Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 23, 2013 | 25.32M |
| May 22, 2013 | 25.32M |
| May 21, 2013 | 25.45M |
| May 20, 2013 | 25.33M |
| May 17, 2013 | 25.80M |
| May 16, 2013 | 24.84M |
| May 15, 2013 | 25.62M |
| May 14, 2013 | 25.39M |
| May 13, 2013 | 26.53M |
| May 10, 2013 | 26.47M |
| May 9, 2013 | 28.36M |
| May 8, 2013 | 30.10M |
| May 7, 2013 | 30.74M |
| May 6, 2013 | 31.59M |
| May 3, 2013 | 32.55M |
| May 2, 2013 | 31.35M |
| May 1, 2013 | 32.25M |
| April 30, 2013 | 32.55M |
| April 29, 2013 | 33.16M |
| April 26, 2013 | 33.15M |
| April 25, 2013 | 34.36M |
| April 24, 2013 | 33.76M |
| April 23, 2013 | 33.76M |
| April 22, 2013 | 37.37M |
| April 19, 2013 | 33.76M |
| April 18, 2013 | 33.82M |
| April 17, 2013 | 34.36M |
| April 16, 2013 | 34.07M |
| April 15, 2013 | 35.45M |
| April 12, 2013 | 38.88M |
| April 11, 2013 | 39.55M |
| April 10, 2013 | 40.98M |
| April 9, 2013 | 40.98M |
| April 8, 2013 | 39.18M |
| April 5, 2013 | 40.37M |
| April 4, 2013 | 40.38M |
| April 3, 2013 | 41.89M |
| April 2, 2013 | 43.39M |
| April 1, 2013 | 42.76M |
| March 28, 2013 | 44.00M |
| March 27, 2013 | 42.79M |
| March 26, 2013 | 42.79M |
| March 25, 2013 | 44.00M |
| March 22, 2013 | 44.66M |
| March 21, 2013 | 44.00M |
| March 20, 2013 | 41.59M |
| March 19, 2013 | 42.19M |
| March 18, 2013 | 42.79M |
| March 15, 2013 | 45.20M |
| March 14, 2013 | 44.61M |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
ECTE Enterprise Value Benchmarks
| Companies | |
|---|---|
| BioScrip | 1.030B |
| Alimera Sciences | 124.94M |
| Herbalife | 5.097B |
ECTE Enterprise Value Rankings
| Overall |
45th percentile 4331 of 8006 |
| Sector |
25th percentile 508 of 686 in Healthcare |
| Industry |
29th percentile 39 of 55 in Drug Manufacturers - Major |
ECTE Enterprise Value Range, Past 5 Years
| Minimum | 4.500M | Feb 17 2009 |
| Maximum | 151.54M | Apr 13 2011 |
| Average | 52.24M |
